Perioperative medicine & outcomes

Outcomes in patients with chronic heart failure undergoing non‐cardiac surgery: a secondary analysis of the METREPAIR international cohort study*

AnaesthesiaPublished Secondary analysis of the MET-REPAIR international prospective cohort study

Primary result · Postoperative MACEResult — go to the resultOdds ratio 2.04 95% CI 1.59–2.60

Authors' conclusion

Stable chronic heart failure is independently associated with major adverse cardiovascular events, mortality and severe postoperative complications when measured 30 days after non-cardiac surgery.

Study context

Population
Patients aged ≥ 45 y with increased cardiovascular risk undergoing non-cardiac surgery
Participants
15,158 patients
Comparison
Stable chronic HF vs no chronic HF
  • Chronic HFn = 3,880
Primary endpoint
Incidence of postoperative MACE
Follow-up
30 days
Methodological detailsmultivariable logistic regression
  • Multivariable logistic regression

Primary result

Postoperative MACE

Odds ratio

2.04

95% CI 1.59–2.60

Chronic HF vs No chronic HF
OR 2.04 (95% CI 1.59–2.60)

As reported in the abstract

Secondary outcomes

OutcomeOR (95% CI)
30-day mortality1.50 (1.17–1.92)
Severe in-hospital complications1.47 (1.30–1.66)

MACE with reduced ejection fraction (subgroup: HF with transthoracic echocardiogram)

OR (95% CI)
Reduced ejection fraction2.0 (1.01–3.81)
MACE with reduced ejection fraction (subgroup: HF with transthoracic echocardiogram) — Transthoracic echocardiography performed in HF
1267 (32.7%)
MACE with reduced ejection fraction (subgroup: HF with transthoracic echocardiogram) — Left ventricular ejection fraction < 40% in HF
146 (11.5%)

Original publication

Outcomes in patients with chronic heart failure undergoing non‐cardiac surgery: a secondary analysis of the METREPAIR international cohort study*. Anaesthesia. Published 15 April 2025. doi:10.1111/anae.16607

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.